ARIZONA – After hosting town halls in Globe and Apache Junction on Monday and meeting with the family of detained restaurant owner Kelly Yu on Tuesday, Senator Ruben Gallego (D-AZ) continued his week in Arizona speaking directly with small business owners, veterans, and veterans’ healthcare providers to hear about the challenges they’re facing due to the Trump administration’s reckless tariffs and chaotic cuts to the VA. On Tuesday and Wednesday, Senator Gallego joined small business leaders for three fireside discussions hosted by the Chandler-Gilbert-Queen Creek Chambers of Commerce, the Greater Phoenix Chamber, and the West Valley Regional Chamber of Commerce. At the events, he spoke about key federal issues shaping Arizona’s

ARIZONA – On Monday, Senator Ruben Gallego (D-AZ) visited the Florence Detention Center to meet with constituents currently in Immigration and Customs Enforcement (ICE) custody and to receive a tour of the facility from ICE personnel. WATCH MORE: Sen. Gallego says Trump administration’s deportations go too far One of the constituents Senator Gallego met with, Amin, fled political violence in Iran in 2001 with his wife, seeking safety from the Ayatollah’s regime. They have lived in the United States for more than two decades, raised two American-born sons – now 18 and 16. Despite their deep ties to the U.S. and lack of criminal history, both parents have

WASHINGTON – Senator Ruben Gallego (D-AZ) called on the Centers for Medicare & Medicaid Services (CMS) to take immediate action to prevent steep increases in Medicare Part D prescription drug premiums for 2026. “I am deeply concerned about the impact premium increases will have on individuals who rely on Medicare Part D for access to essential medications,” Senator Gallego wrote in a letter to CMS Administrator Dr. Mehmet Oz. “Any increase in premiums places an undue financial burden on beneficiaries at a time when Americans are already feeling the strain of rising health care costs.” CMS recently announced the 2026 preliminary rate information for Medicare Part D prescription drug plans,